This panel discussion highlights ideas generated through a series of learning collaborative discussions around optimizing biomarker testing in non-small cell lung cancer (NSCLC). Panelists will share practical insights and effective strategies when navigating some of the complexities of biomarker testing in NSCLC. The panel will discuss tissue handling, reflex testing protocols, use of liquid biopsy, working with reference labs, and the application of new and emerging lung cancer biomarkers.
This activity is supported by an independent educational grant from AstraZeneca and Daiichi Sankyo Inc
This session offers 1.0 CME/CMLE credit.
Faculty/Authors:
Chivukula Mamatha
Schulte Jefree
Lo Ying-Chun
Kim Joseph
Physician Competencies: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement
CME/CMLE Credit: 1.0
Estimated Completion Time: 1 hour
Format: Online Educational Activity
Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).
Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions
To claim CME/CMLE credit for the exercise, do the following:
- Review the Technical Considerations.
- Review the Faculty Disclosures.
- Click Go to Course to view an overview of the modules in this course.
- Click Access to begin the course.
- Submit the course Evaluation.
- Enter the maximum number of credits offered and click Claim CME to register credit.
Faculty Disclosure
Technical Considerations
Release Date: 11/19/2025
Review Date:
Expiration Date: